Yayınlar & Eserler

Yayın Ağı
Makaleler 4
Tümü (4)
SCI-E, SSCI, AHCI (4)
SCI-E, SSCI, AHCI, ESCI (4)
Scopus (4)

1. When side effect becomes the effect: Efficacy of capecitabine in refractory psoriasis

Karakas Y., Vural S., DIKER O., DİZDAR Ö.
DERMATOLOGIC THERAPY , cilt.31, sa.6, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

2. Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience

Sarici F., BABACAN T., Buyukhatipoglu H., Balakan O., SEVER A. R., KERTMEN N., et al.
JOURNAL OF BUON , cilt.21, sa.4, ss.826-831, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

3. Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis

BABACAN T., Buyukhatipoglu H., Balakan O., KERTMEN N., Suner A., Sarici F., et al.
JOURNAL OF BUON , cilt.20, sa.2, ss.479-486, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

4. A retrospective analysis of adjuvant CAF, AC-T and TAC regimens in triple negative early stage breast cancer

Buyukhatipoglu H., BABACAN T., KERTMEN N., Balakan O., Suner A., ATEŞ Ö., et al.
JOURNAL OF BUON , cilt.20, sa.1, ss.22-27, 2015 (SCI-Expanded, Scopus) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 6

1. Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).

Akyildiz A., Guven D. C., Koksal B., Karaoglan B. B., Salim D. K., Sutcuoglu O., et al.
Special Clinical Science Symposia, ELECTR NETWORK, 29 Mayıs 2024, (Özet Bildiri) identifier

2. Neuroendocrine breast cancer A single center experience

TAŞDEMİR V., Kertmen N., CENOLİ A., KESKİN Ö., KARAKAS Y., Diker Ö., et al.
2015 ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015, (Tam Metin Bildiri) Sürdürülebilir Kalkınma identifier identifier

3. Correlation of educational status and clinicopathological characteristics of breast cancer: A single center experience.

Diker O., Babacan T., Buyukhatipoglu H., Kertmen N., Balakan O., Sever A. R., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

4. The retrospective analysis of central nervous system lymphomas: Single-center experience.

Sunar V., Yasar A., Sarici F., Esin E., Diker O., Lacin S., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) identifier

5. Signet ring cell carcinoma of breast: Single center experience.

AKIN S., DIKER O., KERTMEN N., ATEŞ Ö., DİZDAR Ö., YALÇIN Ş., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) identifier

6. Is there any correlation between molecular subtypes and blood groups in breast cancer?

Kucukoztas N., Oguz A., Babacan T., Dizdar O., Rahatli S., Sarici S. F., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri) Sürdürülebilir Kalkınma identifier
Metrikler

Yayın

10

Yayın (WoS)

9

Yayın (Scopus)

5

Atıf (WoS)

6

H-İndeks (WoS)

1

Atıf (Scopus)

4

H-İndeks (Scopus)

1
BM Sürdürülebilir Kalkınma Amaçları